Diagnosis and treatment of malignant pheochromocytoma with 131I-meta-iodobenzylguanidine: a case report
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 17 (2) , 103-108
- https://doi.org/10.1016/0167-8140(90)90097-g
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- New Radionuclide Tracers for the Diagnosis and Therapy of Medullary Thyroid CarcinomaClinical Nuclear Medicine, 1988
- The role of I-131-MIBG in the diagnosis and therapy of carcinoidsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1987
- Update on basic research and clinical experience with metaiodobenzylguanidineMedical and Pediatric Oncology, 1987
- Radioiodinated iodobenzylguanidines for diagnosis and therapyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
- Simultaneous determination of catecholamines and metanephrines in urine by HPLC with fluorometric detectionClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- RADIOPHARMACEUTICAL TREATMENT OF MALIGNANT PHEOCHROMOCYTOMA1984
- [131I]-META-IODOBENZYLGUANIDINE IN TREATMENT OF MALIGNANT PHAEOCHROMOCYTOMASThe Lancet, 1983
- Disseminated malignant phaeochromocytoma: localisation with iodine-131-labelled meta-iodobenzylguanidine.BMJ, 1982
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981